Successful organoid-mediated generation of iPSC-derived CAR-T cells

Artificial thymic organoids (ATOs) allow the selective differentiation of chimeric antigen receptor (CAR)-transduced human iPSCs into CAR-T cells. In this issue of Cell Stem Cell, Wang et al. now use ATOs to produce human CD19 CAR-T cells that mimic conventional CAR-T cells and effectively control t...

Full description

Saved in:
Bibliographic Details
Published in:Cell stem cell 2022-04, Vol.29 (4), p.493-495
Main Author: Kaneko, Shin
Format: Article
Language:English
Subjects:
Animals
Humans
Immunotherapy, Adoptive
Induced Pluripotent Stem Cells
Organoids
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen
T-Lymphocytes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c347t-2109c24539bd940f81b73c364969d4bfa641459a1a29eeec9c105a4e29634fdd3
cites cdi_FETCH-LOGICAL-c347t-2109c24539bd940f81b73c364969d4bfa641459a1a29eeec9c105a4e29634fdd3
container_end_page 495
container_issue 4
container_start_page 493
container_title Cell stem cell
container_volume 29
creator Kaneko, Shin
description Artificial thymic organoids (ATOs) allow the selective differentiation of chimeric antigen receptor (CAR)-transduced human iPSCs into CAR-T cells. In this issue of Cell Stem Cell, Wang et al. now use ATOs to produce human CD19 CAR-T cells that mimic conventional CAR-T cells and effectively control the progression of human CD19 leukemia in an animal model.
doi_str_mv 10.1016/j.stem.2022.03.005
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2648894611</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2648894611</sourcerecordid><originalsourceid>FETCH-LOGICAL-c347t-2109c24539bd940f81b73c364969d4bfa641459a1a29eeec9c105a4e29634fdd3</originalsourceid><addsrcrecordid>eNo9kEtPwzAQhC0EoqXwBzigHLk4-JU4PlYRL6kSiJaz5dibKlXSFDtB4t_jqIXTrrQzs6MPoVtKUkpo_rBLwwBdyghjKeEpIdkZmtNCZlhJKc_jrrjAmSJqhq5C2EWBpEReohnPuMpoweaoXI_WQgj12Ca935p93zjcgWvMAC7Zwh68GZp-n_R10ryvS-zAN9_xVC4_8Cax0LbhGl3Upg1wc5oL9Pn0uClf8Ort-bVcrrDlQg6YUaIsE_F15ZQgdUEryS3PhcqVE1VtckFFpgw1TAGAVZaSzAhgKueido4v0P0x9-D7rxHCoLsmTA3MHvoxaJaLolAipzRK2VFqfR-Ch1offNMZ_6Mp0RM8vdMTPD3B04TryCaa7k75YxUR_Fv-aPFf8FRqmQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2648894611</pqid></control><display><type>article</type><title>Successful organoid-mediated generation of iPSC-derived CAR-T cells</title><source>BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS</source><creator>Kaneko, Shin</creator><creatorcontrib>Kaneko, Shin</creatorcontrib><description>Artificial thymic organoids (ATOs) allow the selective differentiation of chimeric antigen receptor (CAR)-transduced human iPSCs into CAR-T cells. In this issue of Cell Stem Cell, Wang et al. now use ATOs to produce human CD19 CAR-T cells that mimic conventional CAR-T cells and effectively control the progression of human CD19 leukemia in an animal model.</description><identifier>ISSN: 1934-5909</identifier><identifier>EISSN: 1875-9777</identifier><identifier>DOI: 10.1016/j.stem.2022.03.005</identifier><identifier>PMID: 35395182</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Humans ; Immunotherapy, Adoptive ; Induced Pluripotent Stem Cells ; Organoids ; Receptors, Antigen, T-Cell ; Receptors, Chimeric Antigen ; T-Lymphocytes</subject><ispartof>Cell stem cell, 2022-04, Vol.29 (4), p.493-495</ispartof><rights>Copyright © 2022 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c347t-2109c24539bd940f81b73c364969d4bfa641459a1a29eeec9c105a4e29634fdd3</citedby><cites>FETCH-LOGICAL-c347t-2109c24539bd940f81b73c364969d4bfa641459a1a29eeec9c105a4e29634fdd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35395182$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaneko, Shin</creatorcontrib><title>Successful organoid-mediated generation of iPSC-derived CAR-T cells</title><title>Cell stem cell</title><addtitle>Cell Stem Cell</addtitle><description>Artificial thymic organoids (ATOs) allow the selective differentiation of chimeric antigen receptor (CAR)-transduced human iPSCs into CAR-T cells. In this issue of Cell Stem Cell, Wang et al. now use ATOs to produce human CD19 CAR-T cells that mimic conventional CAR-T cells and effectively control the progression of human CD19 leukemia in an animal model.</description><subject>Animals</subject><subject>Humans</subject><subject>Immunotherapy, Adoptive</subject><subject>Induced Pluripotent Stem Cells</subject><subject>Organoids</subject><subject>Receptors, Antigen, T-Cell</subject><subject>Receptors, Chimeric Antigen</subject><subject>T-Lymphocytes</subject><issn>1934-5909</issn><issn>1875-9777</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo9kEtPwzAQhC0EoqXwBzigHLk4-JU4PlYRL6kSiJaz5dibKlXSFDtB4t_jqIXTrrQzs6MPoVtKUkpo_rBLwwBdyghjKeEpIdkZmtNCZlhJKc_jrrjAmSJqhq5C2EWBpEReohnPuMpoweaoXI_WQgj12Ca935p93zjcgWvMAC7Zwh68GZp-n_R10ryvS-zAN9_xVC4_8Cax0LbhGl3Upg1wc5oL9Pn0uClf8Ort-bVcrrDlQg6YUaIsE_F15ZQgdUEryS3PhcqVE1VtckFFpgw1TAGAVZaSzAhgKueido4v0P0x9-D7rxHCoLsmTA3MHvoxaJaLolAipzRK2VFqfR-Ch1offNMZ_6Mp0RM8vdMTPD3B04TryCaa7k75YxUR_Fv-aPFf8FRqmQ</recordid><startdate>20220407</startdate><enddate>20220407</enddate><creator>Kaneko, Shin</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220407</creationdate><title>Successful organoid-mediated generation of iPSC-derived CAR-T cells</title><author>Kaneko, Shin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c347t-2109c24539bd940f81b73c364969d4bfa641459a1a29eeec9c105a4e29634fdd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Animals</topic><topic>Humans</topic><topic>Immunotherapy, Adoptive</topic><topic>Induced Pluripotent Stem Cells</topic><topic>Organoids</topic><topic>Receptors, Antigen, T-Cell</topic><topic>Receptors, Chimeric Antigen</topic><topic>T-Lymphocytes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kaneko, Shin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cell stem cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaneko, Shin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful organoid-mediated generation of iPSC-derived CAR-T cells</atitle><jtitle>Cell stem cell</jtitle><addtitle>Cell Stem Cell</addtitle><date>2022-04-07</date><risdate>2022</risdate><volume>29</volume><issue>4</issue><spage>493</spage><epage>495</epage><pages>493-495</pages><issn>1934-5909</issn><eissn>1875-9777</eissn><abstract>Artificial thymic organoids (ATOs) allow the selective differentiation of chimeric antigen receptor (CAR)-transduced human iPSCs into CAR-T cells. In this issue of Cell Stem Cell, Wang et al. now use ATOs to produce human CD19 CAR-T cells that mimic conventional CAR-T cells and effectively control the progression of human CD19 leukemia in an animal model.</abstract><cop>United States</cop><pmid>35395182</pmid><doi>10.1016/j.stem.2022.03.005</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1934-5909
ispartof Cell stem cell, 2022-04, Vol.29 (4), p.493-495
issn 1934-5909
1875-9777
language eng
recordid cdi_proquest_miscellaneous_2648894611
source BACON - Elsevier - GLOBAL_SCIENCEDIRECT-OPENACCESS
subjects Animals
Humans
Immunotherapy, Adoptive
Induced Pluripotent Stem Cells
Organoids
Receptors, Antigen, T-Cell
Receptors, Chimeric Antigen
T-Lymphocytes
title Successful organoid-mediated generation of iPSC-derived CAR-T cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T12%3A03%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20organoid-mediated%20generation%20of%20iPSC-derived%20CAR-T%20cells&rft.jtitle=Cell%20stem%20cell&rft.au=Kaneko,%20Shin&rft.date=2022-04-07&rft.volume=29&rft.issue=4&rft.spage=493&rft.epage=495&rft.pages=493-495&rft.issn=1934-5909&rft.eissn=1875-9777&rft_id=info:doi/10.1016/j.stem.2022.03.005&rft_dat=%3Cproquest_cross%3E2648894611%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c347t-2109c24539bd940f81b73c364969d4bfa641459a1a29eeec9c105a4e29634fdd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2648894611&rft_id=info:pmid/35395182&rfr_iscdi=true